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The enzymes involved in synthesizing the bacterial cell wall are attractive targets
for the design of antibacterial compounds, since this pathway is essential for
bacteria and is absent in animals, particularly humans. A survey of the genome
of a bacterium that belongs to the phylum Verrucomicrobia, the closest free-living
relative to bacteria from the Chlamydiales phylum, shows genetic evidence that
Verrucomicrobium spinosum possesses a novel fusion open reading frame (ORF)
annotated by the locus tag (VspiD_010100018130). The ORF, which is predicted
to encode the enzymes UDP-N-acetylenolpyruvoylglucosamine reductase (MurB)
and UDP-N-acetylmuramate:L-alanine ligase (MurC) that are involved in the
cytoplasmic steps of peptidoglycan biosynthesis, was cloned. In vivo analyses
using functional complementation showed that the fusion gene was able to
complement Escherichia coli murB and murC temperature sensitive mutants. The
purified recombinant fusion enzyme (MurB/CVs) was shown to be endowed with
UDP-N-acetylmuramate:L-alanine ligase activity. In vitro analyses demonstrated that
the latter enzyme had a pH optimum of 9.0, a magnesium optimum of 10mM and
a temperature optimum of 44–46◦C. Its apparent Km values for ATP, UDP-MurNAc,
and L-alanine were 470, 90, and 25 µM, respectively. However, all attempts to
demonstrate an in vitro UDP-N-acetylenolpyruvoylglucosamine reductase (MurB)
activity were unsuccessful. Lastly, Hidden Markov Model-based similarity search
Naqvi et al. MurB/MurC Fusion Protein from Verrucomicrobium spinosum
and phylogenetic analysis revealed that this fusion enzyme could only be identified in
specific lineages within the Verrucomicrobia phylum.
Keywords: MurB, MurC, UDP-N-acetylenolpyruvoylglucosamine reductase, UDP-N-acetylmuramate:L-alanine
ligase, fusion enzyme, bacterial cell wall, peptidoglycan, Verrucomicrobium spinosum
INTRODUCTION
Bacteria belonging to the Verrucomicrobia phylum are Gram-
negative heterotrophic organisms that are generally found in
soil and fresh water environments. The phylum is considered
to have two sister phyla, Chlamydiae and Lentisphaerae (Cho
et al., 2004). Members of the Verrucomicrobia are of interest
due to their close evolutionary relationship to bacteria from
the genus Chlamydia in addition to their unusual morphology
of possessing wart-like and tube-like appendages that protrude
from the cell membrane, commonly referred to as prosthecae
(Wagner and Horn, 2006; McGroty et al., 2013). Most of
the research that has been done with bacteria from this
phylum has been done using Verrucomicrobium spinosum as
the model organism. The bacterium was found to employ the
type III secretion system and is pathogenic toward Drosophila
melanogaster and Caenorhabditis elegans (Sait et al., 2011). In
addition, research from our group recently demonstrated that the
bacterium employs the L,L-diaminopimelate aminotransferase
(DapL) pathway for the synthesis of meso-diaminopimelate
involved both in the cross-linking of peptidoglycan (PG) and
in lysine anabolism (Nachar et al., 2012; McGroty et al.,
2013). Due to the morphological complexity and unusual
cellular plan of V. spinosum, the synthesis of PG is of
interest to our group given its close relationship to the
pathogenic organisms from the genus Chlamydia. In addition,
the recent discovery of PG in Chlamydia has made this
project more intriguing, given the fact that even though β-
lactam antibiotics are effective against Chlamydia, definitive
evidence of PG in Chlamydial species has been lacking until
this recent discovery (Pilhofer et al., 2013; Packiam et al.,
2015).
Cell wall PG (also namedmurein) is ubiquitous in the bacterial
domain. The PG of bacteria is composed of tandem repeats of
the sugars N-acetylglucosamine (GlcNAc) and N-acetylmuramic
acid (MurNAc) cross-linked by a short peptide stem containing
usually L-lysine or meso-diaminopimelate at the third position
(Park, 1987; Vollmer et al., 2008). Due to its rigid structure
and tensile strength, the PG has several overarching roles such
as protecting the osmotic integrity of the cell in addition to
maintaining the shape of the bacteria.
The synthesis of PG in bacteria occurs via a pathway that
has three distinct steps: the cytoplasmic, membrane, and
periplasmic steps. In the cytoplasmic steps, the nucleotide sugar-
linked precursor UDP-MurNAc-pentapeptide is synthesized
in a series of reactions catalyzed by the enzymes MurA,
MurB, MurC, MurD, MurE, MurF, and Ddl (Figure 1)
(Barreteau et al., 2008). The next steps in PG formation
are the synthesis of the lipid precursor intermediates,
undecaprenyl-diphospho-MurNAc-pentapeptide (lipid I) and
undecaprenyl-diphospho-MurNAc-(pentapeptide)-GlcNAc
(lipid II), by the enzymes MraY and MurG, respectively; these
reactions occur at the level of the cytoplasmic membrane
(Bouhss et al., 2008). The ultimate steps in the pathway are the
transglycosylation and transpeptidation reactions, characterized
by the polymerization of the sugar-peptide units and their
incorporation into the growing PG; these reactions take place in
the extra-cytoplasmic space and are catalyzed by the penicillin-
binding proteins (PBPs) (Figure 1) (Scheffers and Pinho,
2005).
The first three cytoplasmic steps of the PG synthesis pathway,
which are the topic of this paper, are as follows. First, UDP-
N-acetylglucosamine-1-carboxyvinyltransferase (MurA, EC
2.5.1.7) catalyzes the transfer of the enolpyruvyl moiety from
phosphoenolpyruvate to the 3′-hydroxyl end of UDP-GlcNAc
to produce UDP-N-acetylenolpyruvoylglucosamine (UDP-
GlcNAc-EP) (Figure 1) (Marquardt et al., 1992; Wanke et al.,
1992). Then, UDP-N-acetylenolpyruvoylglucosamine reductase
(MurB, EC 1.3.1.98) catalyzes the reduction of the enolpyruvyl
moiety of UDP-GlcNAc-EP to lactyl ether to produce UDP-N-
acetylmuramic acid (UDP-MurNAc) (Figure 2A) (Benson et al.,
1993; Tayeh et al., 1995). Finally, UDP-N-acetylmuramate:L-
alanine ligase (MurC, EC 6.3.2.8) catalyzes the third reaction,
which consists in the addition of L-Ala to the carboxyl group
of UDP-MurNAc to produce UDP-MurNAc-L-Ala (Figure 2B)
(Liger et al., 1995; Falk et al., 1996; Gubler et al., 1996).
Here we report the identification and biochemical partial
characterization of a novel MurB/C fusion enzyme from V.
spinosum. While in vitro assays demonstrate that the enzyme
is able to catalyze the ligase (MurC) reaction, attempts to
demonstrate the reductase (MurB) activity in vitro were
unsuccessful. Nevertheless, in vivo analyses demonstrated that
the fusion gene is able to functionally complement two
Escherichia coli strains that harbor mutations in the murB
and murC genes. Given the facts that (i) the MurB and
MurC enzymes are not normally fused and are encoded by
separate ORFs as is the case of the two E. coli proteins (Pucci
et al., 1992; Liger et al., 1995), and (ii) the PG biosynthesis
pathway is essential and is only present in the bacterial
domain, the identification and characterization of this unusual
fusion enzyme involved in PG biosynthesis in V. spinosum,
a close relative of the pathogenic organism Chlamydia, is
intriguing. This study has the potential to contribute to the
further understanding of the kinetic, physical and structural
properties of enzymes involved in the synthesis of PG in order
to facilitate the development and/or discovery of antibacterial
compounds that are able to combat current and emerging
bacterial infections and diseases, especially those that are deemed
to be resistant to antibiotics that are currently used in a clinical
setting.
Frontiers in Microbiology | www.frontiersin.org 2 March 2016 | Volume 7 | Article 362
Naqvi et al. MurB/MurC Fusion Protein from Verrucomicrobium spinosum
FIGURE 1 | Schematic representation depicting the three stages of PG biosynthesis in bacteria. The cytoplasmic, membrane, and periplasmic steps are
shown. The abbreviations of the enzymes are as follows: MurA, UDP-N-acetylglucosamine 1-carboxyvinyltransferase; MurB, UDP-N-acetylenolpyruvoylglucosamine
reductase; MurC, UDP-N-acetylmuramate:L-alanine ligase; MurD, UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase; MurE, UDP-N-acetylmuramoyl-L-
alanyl-D-glutamate:2,6-diaminopimelate ligase or UDP-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase; MurF, UDP-N-acetylmuramoyl-tripeptide:D-
alanyl-D-alanine ligase; Ddl, D-alanine:D-alanine ligase; MraY, phospho-N-acetylmuramoyl-pentapeptide transferase; MurG, undecaprenyl-diphospho-N-
acetylmuramoyl-pentapeptide β-N-acetylglucosaminyl transferase; and PBPs, penicillin-binding proteins. The enzymatic activities theoretically carried by the MurB/C
fusion enzyme from V. spinosum are shaded in black. UDP-GlcNAc-EP stands for UDP-N-acetylenolpyruvoylglucosamine.
MATERIALS AND METHODS
Materials
L-[14C]Ala (5.99 GBq.mmol−1) and L-[14C]Ser (6.07
GBq.mmol−1) were purchased from Perkin Elmer, [14C]Gly
(3.88 GBq.mmol−1) from CEA, and UDP-[14C]GlcNAc (2
GBq.mmol−1) from ARC Isobio. UDP-[14C]MurNAc was
prepared according to published procedure (Bouhss et al.,
2002). UDP-GlcNAc-EP was purchased from the BaCWAN
facility.
V. spinosum Growth Conditions/Plasmids
and Strains used in this Study
V. spinosum DSM 4136T was cultured in R2A medium
supplemented with 5% (w/v) artificial sea water at 26◦C
(Schlesner, 1987). The plasmids and strains used in this study are
listed in Table 1.
Domain Mapping of MurB/CVs
Identification
The protein family (Pfam) domains of MurB/CVs were
identified using the Pfam server (http://pfam.sanger.ac.uk/)
and (http://pfam.janelia.org/) (Finn et al., 2014). The conserved
domain database (CDD) (http:// www.ncbi.nlm.nih.gov/
Structure/cdd/cdd.shtml) was used to identify the domains of
MurB/CVs (Marchler-Bauer et al., 2015).
Identification of Lineages Containing
Fused MurB/C Protein and Phylogenetic
Analysis of MurB and MurC Proteins
Publicly available draft and complete genome sequences
belonging to members of the phylum Planctomycetes,
Verrucomicrobia, Chlamydiae, and Lentisphaerae (PVC)
were downloaded from NCBI. The proteomes were re-predicted
with Prodigal version 2.6 (Hyatt et al., 2010) and then used for
phylogenomic tree construction with PhyloPhlAN (Segata et al.,
2013). The manually curated database of protein families known
as TIGFAMs was used to identify MurB (TIGR00179) and
MurC (TIGR00182) proteins (Haft et al., 2003). The predicted
whole proteomes were subjected to similarity search based on
the hidden Markov model (HMM) profiles TIGR00179 and
TIGR00182 using HMMsearch (–cut_tc option) (Eddy, 2011),
and species containing unusual composition of MurB andMurC,
i.e., fused MurB/C, missing MurB, and/or missing MurC, were
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FIGURE 2 | Enzymatic reactions catalyzed by the MurB/C fusion
enzyme. (A) Reaction catalyzed by UDP-N-acetylenolpyruvoylglucosamine
reductase (MurB). (B) Reaction catalyzed by UDP-N-acetylmuramate:
L-alanine ligase (MurC).
annotated in the constructed species tree. Additionally, the
gene organization of contigs containing the fused murB/C open
reading frame (ORF) was further analyzed with EasyFig version
2.1 (Sullivan et al., 2011). Additional MurB and MurC proteins
were also mined from the UniProt (http://www.uniprot.org/)
(The UniProt Consortium) to be included for phylogenetic
analysis. Briefly, the proteins were aligned and trimmed using
mafft-linsi and trimal (-gappyout setting) (Capella-Gutiérrez
et al., 2009; Katoh and Standley, 2013), and phylogenetic
inference was performed using IQ-TREE version 1.3.10
(Nguyen et al., 2014) and visualized using FigTree version 1.42
(http://tree.bio.ed.ac.uk/software/figtree/).
PCR Amplification and Cloning of the V.
spinosum murB/C Open Reading Frame
(ORF)
The ORF annotated by the locus tag (VspiD_010100018130)
UDP-N-acetylenolpyruvoylglucosamine reductase /UDP-N-
acetylmuramate:L-alanine ligase was amplified by PCR using
the primers murB/CVs-forward (5
′-CACCATGAATCACGCC
GTCGTCAGTTTGTTGAAG-3′) and murB/CVs-reverse (5
′-
GTCGACCTATAGCGGAAGCGGTTCCTCTTCGCCAAT-3′).
The underlined sequence represents the restriction enzyme
site used to facilitate sub-cloning of the ORF while the bold
sequences represent initiation and termination codons. The PCR
reaction contained 12 pmol of forward and reverse primers,
1mM MgSO4, 0.5 mM of each of the four deoxynucleotide
triphosphates, 0.5 ng of genomic DNA and 1 unit of Platinum
Pfx DNA polymerase (Invitrogen Corporation, Carlsbad, CA,
USA). PCR conditions were: 1 cycle at 94◦C for 2min, followed
by 30 cycles of 94◦C for 15 s, 60◦C for 30 s, and 72◦C for 3
min. The murB/C PCR fragment was ligated into the plasmid
pET100D/topo (Invitrogen Corporation, Carlsbad, CA, USA)
TABLE 1 | Plasmids and strains used in this study.
Plasmids and strains Sources/References
PLASMIDS
pET100D/topo Invitrogen, USA
pBAD33 Guzman et al., 1995
pET100D::murB/CVs This study
pBAD33::murB/CVs This study
pTrcHis60 Pompeo et al., 1998
pTrcHis60::murBVs-1 This study
pTrcHis60::murBVs-2 This study
pTrcHis60::murCVs-1 This study
pTrcHis60::murCVs-2 This study
pTrcHis60::murCEc Liger et al., 1995
STRAINS
Verrucomicrobium spinosum DSM 4136T Schlesner, 1987
5-alpha competent cells New England Biolabs, USA
Rosetta codon plus RIPL Agilent, Technologies, USA
Rosetta (DE3) pLysS Novagen, USA
E. coli murB (ST5) CGSC Strain # 6442 Matsuzawa et al., 1969; Miyakawa
et al., 1972
E. coli murC (ST222) CGSC Strain # 5988 Miyakawa et al., 1972
E. coli murC (H1119) Wijsman, 1972
E. coli murB (pBAD33) This study
E. coli murC (pBAD33) This study
E. coli murB (pBAD33::murB/CVs) This study
E. coli murC (pBAD33::murB/CVs) This study
to produce the plasmid pET100D::murB/CVs. The recombinant
protein encoded by this plasmid carries an N-terminal
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDHPFT
additional sequence containing a hexa-histidine tag (bold)
derived from the pET100D plasmid. To confirm the fidelity of
the PCR reaction, the ORF was sequenced from pET100D using
the T7 promoter primer, 5′-TAATACGACTCACTATAGGG-3′
and the T7 reverse primer, 5′-TAGTTATTGCTCAGCGGTGG-
3′. The cloned murB/C ORF was 100% identical to the sequence
deposited in the Integrated Microbial Genomes public database
(http://img.jgi.doe.gov/cgi-bin/w/main.cgi).
Cloning of murC and murB Domains
The murC and murB domains of the MurB/CVs fusion protein
were also cloned separately in expression vectors, as follows.
The murC domain sequence (two different end points were
chosen) was amplified by PCR by using murCVs-forward
(5′-GCGCTCATGAATCACGCCGTCGTCAGTTTGTTGA
AG-3′) as the forward primer and either murCVs-reverse-1
(5′-GCGCAGATCTGCCTTCGCGATTGAGCACCGTAGT
GAG-3′) or murCVs-reverse-2 (5
′-GCGCAGATCTGACCGT
GCCACCGCCTTCGCGATTGAG-3′) as the reverse primer,
designed to end the MurC domain at the Gly477 and Val481
residues, respectively. The underlined sequences correspond
to introduced BspHI and BglII restriction sites and the murC
gene initiation codon is indicated in bold. The two PCR
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products were digested by BspHI and BglII and inserted between
the compatible NcoI and BglII sites of the expression vector
pTrcHis60 that allows expression of proteins with a C-terminal
hexa-histidine tag under the control of the IPTG-inducible
trc promoter (Pompeo et al., 1998). The two plasmids thus
generated, pTrcHis60::murCVs-1 and pTrcHis60::murCVs-2,
directed expression of Met1-Gly477 and Met1-Val481 fragments
from the MurB/CVs fusion protein (770 residues in total),
respectively, fused to a C-terminal tag extension consisting in
Arg-Ser-His6.
Similarly, the murB domain sequence (two different starting
points were chosen) was amplified by using either murBVs-
forward-1 (5′-GAAGCCATGGGCACGGTCAAGCTCTATGA
GCCGATG-3′) or murBVs-forward-2 (5
′-GCGCTCATGAAGC
TCTATGAGCCGATGGCCAACCAC-3′) as the forward primer
and murBVs-reverse (5
′-GCGCAGATCTTAGCGGAAGCGG
TTCCTCTTCGCCAATG-3′) as the reverse primer. NcoI, BspHI
and BglII restriction sites introduced in these sequences are
underlined and the murB gene initiation codons are indicated
in bold. The two PCR products were digested by NcoI or
BspHI and BglII and inserted between the compatible NcoI
and BglII sites of the vector pTrcHis60. The two plasmids thus
generated, pTrcHis60::murBVs-1 and pTrcHis60::murBVs-2,
directed expression of the Gly479-Leu770 and Lys482-Leu770
fragments (preceded by a Met residue) from the MurB/CVs
fusion protein, respectively, here too with a C-terminal tag
consisting in Arg-Ser-His6.
Expression and Purification of
Recombinant MurB/CVs
The E. coli Rosetta (DE3) pLysS strain (Novagen) was
transformed with the plasmid pET100D::murB/CVs and grown
at 37◦C in 2YT medium containing 50 µg.mL−1 ampicillin
and 25 µg.mL−1 chloramphenicol. An overnight pre-culture of
the resulting strain was used to inoculate 2YT medium (2-liter
cultures). The culture was incubated with shaking at 37◦C.When
the optical density reached 0.9, the temperature of the culture
was decreased to 20◦C and IPTG was added at a 1mM final
concentration. Growth was continued for 18 h at 20◦C. Cells
were harvested at 4◦C and the pellet was washed with cold 20
mM phosphate buffer, pH 7.2, containing 1 mM dithiothreitol
(buffer A). Bacteria were resuspended in buffer A (12mL) and
disrupted by sonication in the cold using a Bioblock Vibracell
72412 sonicator. The resulting suspension was centrifuged at 4◦C
for 30min at 200,000 × g with a Beckman TL100 apparatus, and
the pellet was discarded. The supernatant was kept at−20◦C.
The His6-tagged protein was purified on Ni
2+-
nitrilotriacetate (Ni2+-NTA)-agarose following the
manufacturer’s recommendations (Qiagen). All procedures
were performed at 4◦C. The supernatant was mixed for 1 h
with the polymer previously washed with buffer A containing
0.3M KCl and 10mM imidazole. Washing and elution steps
were performed with a discontinuous gradient of imidazole
(20–300mM) in buffer A containing 0.3M KCl. Protein contents
were analyzed by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and relevant fractions were
pooled and dialyzed against 100 volumes of buffer A. At this
step, precipitation of a significant part of the protein was
observed. The non-precipitated protein was concentrated on
an Amicon Ultra 50,000 molecular mass cutoff filter. Glycerol
(10% final concentration) was added for storage at −20◦C.
Protein concentrations were determined by quantitative amino
acid analysis with a Hitachi L8800 analyzer (ScienceTec) after
hydrolysis of samples at 105◦C for 24 h in 6M HCl containing
0.05% 2-mercaptoethanol. No attempts were made to remove
the additional sequence containing the hexa-histidine tag after
protein purification.
Construction of the Plasmid to Facilitate
Functional Complementation
The plasmid used for functional complementation of the E. coli
murB and murC mutants was produced by sub-cloning the XbaI
and SalI fragment from the pET100D::murB/CVs plasmid into
pBAD33 to produce the plasmid pBAD33::murB/CVs, which is
under control of the arabinose inducible promoter (Guzman
et al., 1995). The protein produced from the pBAD33 construct
is identical to the protein produced from the pET100D construct.
Note that there is an XbaI site 20 base pairs upstream of the
ribosome binding site of the pET100D vector that was used to
facilitate sub-cloning from pET100D into pBAD33.
Functional Complementation of the E. coli
murB and murC Thermosensitive Mutants
The E. coli murB mutant (ST5-strain #6442) [thr-1, araC14,
leuB6 (Am), secA216, fhuA61, lacY1, galT23, λ− trp-84, his-
215, thyA710, rpsL263 (strR), xylA5, mtl-1, murB1-(ts), thi-
1] and murC mutant (ST222-strain #5988) [thr-1, araC14,
leuB6 (Am), murC3(ts), secA216, fhuA61, lacY1, galT23, λ−
trp-84, his-215, thyA710, rpsL263 (strR), xylA5, mtl-1, thi-
1] were both obtained from the Coli Genetic Stock Center
(http://cgsc.biology.yale.edu/). These mutants were transformed
with the pBAD33 vector or the pBAD33::murB/CVs plasmid and
transformants were selected on LB agar medium supplemented
with 50 µg.mL−1 thymine, 34 µg.mL−1 chloramphenicol, and
0.2% (w/v) arabinose at 30◦C. Colonies were then replica-plated
onto LB agar medium plus 0.2% (w/v) arabinose and 10µg.mL−1
thymine. Liquid cultures were also performed in LB medium
supplemented with arabinose and thymine. In both cases, the
growth phenotype was assessed at 30 and 42◦C for up to 24 h.
As described above, the individual murC and murB domains
from the murB/CVs fusion gene were also cloned separately
in the pTrcHis60 vector that allows high-level gene expression
under control of the strong IPTG-dependent trc promoter. The
resulting plasmids pTrcHis60::murBVs and pTrcHis60::murCVs
were then tested for functional complementation, using the E.
coli murB mutant ST5 and the murC mutant strain H1119
(Wijsman, 1972), respectively. Transformants were selected on
LB agarmedium supplemented with 100µg.mL−1 ampicillin and
50 µg.mL−1 thymine at 30◦C and were subsequently replicated
on similar plates incubated at 30◦C or 42◦C, in the presence
or absence of 0.5mM IPTG. Growth was observed after 24 h of
incubation.
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Determination of the Kinetic Constants of
the MurC Activity
The standard MurC activity assay (Liger et al., 1995) measured
the formation of UDP-MurNAc-L-Ala in a mixture (final
volume, 40 µL) containing 100mM Tris-HCl, pH 9.0, 10mM
MgCl2, 3mM ATP, 10mM ammonium sulfate, 0.5mg.mL
−1
bovine serum albumin (BSA), 0.9mM UDP-MurNAc, 0.3mM
L-[14C]Ala (400 Bq), and enzyme (20 µL of an appropriate
dilution in buffer A). For the determination of the Km values for
UDP-MurNAc, UDP-[14C]MurNAcwas used as the radiolabelled
substrate.
In all cases, the mixtures were incubated for 30 min at 37◦C
and the reactions were stopped by the addition of glacial acetic
acid (10 µL) followed by lyophilization. Radioactive substrate
and product were then separated by HPLC on a Nucleosil 100C18
5 µm column (150 × 4.6mm; Alltech France) using 50mM
ammonium formate, pH 3.2, at a flow rate of 0.6mL.min−1.
Radioactivity was detected with a flow detector (model LB506-
C1, Berthold) using the Quicksafe Flow 2 scintillator (Zinsser
Analytic) at 0.6 mL.min−1. Quantification was performed with
the Radiostar software (Berthold).
For the determination of the kinetic constants, the same
assay was used with various concentrations of one substrate
and fixed concentrations of the others. In all cases, the enzyme
concentration was chosen so that substrate consumption was
<20%, the linearity being ensured within this interval even at the
lowest substrate concentration. Data were fitted to the equation
v = VmaxS/(Km + S) by the Levenberg-Marquardt method
(Press et al., 1986), where v is the initial velocity and S is the
substrate concentration, and values ± standard deviation at 95%
of confidence were calculated. TheMDFitt software developed by
M. Desmadril (I2BC, Orsay, France) was used for this purpose.
In vitro Spectrophotometric Assay of the
MurB Activity
The MurB spectrophotometic assay was performed as described
previously (Benson et al., 1993). The reaction mixture contained,
in a final volume of 100µL, 50mMTris-HCl, pH 8.0, 20mMKCl,
0.5mM dithiothreitol, 0.1mM UDP-GlcNAc-EP, and 0.15mM
NADPH. The mixture was placed in a 1- cm path length cell
and the reaction was started by the addition of the enzyme. The
decrease in NADPH absorbance at 340 nm was monitored with a
Jasco V-630 spectrophotometer.
In vitro Coupled Assay of the MurA/MurB
Activities
The reaction mixture contained, in a final volume of 40 µL,
50mM Tris-HCl, pH 7.6, 25mM KCl, 0.1 mM NADPH, 55
µM UDP-[14C]GlcNAc (500 Bq), 75 µM phosphoenolpyruvate,
E. coli MurA (1 µg), and enzyme. In some experiments, 5mM
ATP, 10mM MgCl2, and 0.15mM L-Ala were included. After 30
min at 37◦C, the reaction was stopped by the addition of glacial
acetic acid (8 µL) followed by lyophilization. The radioactive
substrate and product were separated on a Nucleosil 100C18
5 µm column (150 × 4.6mm; Alltech France) using 50 mM
ammonium formate, pH 3.2, at a flow rate of 0.6mL.min−1.
Detection and quantification of the radioactivity were performed
as described above. The retention times for UDP-GlcNAc, UDP-
GlcNAc-EP, UDP-MurNAc, and UDP-MurNAc-L-Ala were 6, 10,
12, and 20min, respectively.
MurB/CVs Cleavage Assay
For the cleavage assay, V. spinosum was grown in liquid medium
R2A medium supplemented with 5% (w/v) artificial sea water at
26◦C for 5 days. Following centrifugation, the cells were lysed by
sonication in the following buffer systems 50mM Tris-HCl, pH
7.6, 50mM Tris-HCl, pH 8.5, and 50mM HEPES-KOH, pH 7.6.
The purified recombinant enzyme (7.5 µg) was incubated with
15 µg of V. spinosum extract at 30◦C. The proteins were resolved
on a 10% (w/v) acrylamide gel and stained with Coomassie blue
for visualization. Protein concentration was measured using the
Bradford assay with BSA as the standard (Bradford, 1976).
RESULTS
Identification of the MurB/C Fusion
Enzyme from V. spinosum
The complete set of genes in V. spinosum required for the de
novo synthesis of PG was initially identified from a comparative
analysis of the V. spinosum proteome using the known PG
biosynthesis proteins as queries (Nachar et al., 2012). The
search revealed an anomaly when it was realized that both the
MurB and MurC proteins were encoded by a single locus tag
VspiD_010100018130 (Table 2).
Domain Mapping of the MurB/C Fusion
Enzyme from V. spinosum
The length of the MurB and MurC E. coli proteins are 342
and 491 residues, respectively, and the lengths of the MurB/C
fusion enzyme protein is 770 residues. As such, we were
interested to assess if the fusion enzyme had the domains that
are indicative of typical MurB and MurC enzymes. Domains
were identified using the NCBI’s CDD and the protein families
database (Pfam) (Finn et al., 2014; Marchler-Bauer et al., 2015).
The CDD and Pfam analyses resulted in the identification of
the following domains: (1) the Mur ligase catalytic domain
(Pfam01225), (2) theMur ligase middle domain (Pfam08245), (3)
the Mur ligase family amino acid-binding domain (Pfam02875),
(4) the FAD-binding domain (Pfam01565), and (5) the UDP-
N-acetylenolpyruvoylglucosamine reductase C-terminal domain
(Pfam02873). This analysis also demonstrated that the residues
responsible for the MurC activity were located toward the N-
terminal end of the fusion enzyme, while those for the MurB
activity are located toward the C-terminal end. MurC and MurB
are separated by a linker region of ∼100 residues as depicted in
the schematic. For comparison, the figure also depicts the domain
structures of the E. coliMurB and MurC enzymes (Figure 3).
The murB/CVs Gene is able to Functionally
Complement the E. coli murB and murC
Mutants
The E. coli strains ST5 and ST222 obtained from the Coli
Genetic Stock Center harbor mutations in the murB and murC
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TABLE 2 | List of PG biosynthesis genes from V. spinosum.
Protein symbol Gene product name EC # Locus Tag
MurA UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2.5.1.7 VspiD_010100011745
MurB UDP-N-acetylenolpyruvoylglucosamine reductase 1.3.1.98 VspiD_010100018130
MurC UDP-N-acetylmuramate:L-alanine ligase 6.3.2.8 VspiD_010100018130
MurI Glutamate racemase 5.1.1.3 VspiD_010100008415
MurD UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase 6.3.2.9 VspiD_010100019115
MurE UDP-N-acetylmuramoyl-L-alanyl-D-glutamate:2,6-diaminopimelate ligase 6.3.2.13 VspiD_010100019130
MurF UDP-N-acetylmuramoyl-tripeptide:D-alanyl-D-alanine ligase 6.3.2.10 VspiD_010100019125
AlaR Alanine racemase 5.1.1.1 VspiD_010100000100
Ddl D-alanine:D-alanine ligase 6.3.2.4 VspiD_010100018175
MraY Phospho-N-acetylmuramoyl-pentapeptide transferase 2.7.8.13 VspiD_010100019120
MurG Undecaprenyl-diphospho-N-acetylmuramoyl-pentapeptide β-N-acetylglucosaminyl transferase 2.4.1.227 VspiD_010100019100
UppP Undecaprenyl-diphosphate phosphatase 3.6.1.27 VspiD_010100026230
PBP D-alanyl-D-alanine carboxypeptidase-class C 3.4.16.4 VspiD_010100024635
PBP Multimodular transpeptidase-transglycosylase-class A 2.4.1.129 VspiD_010100022270
PBP Penicillin-binding protein 1C- class A 2.4.1.129 VspiD_010100006740
PBP Penicillin-binding protein 2-class A 2.4.1.129 VspiD_010100020475
PBP Peptidoglycan transpeptidase-class B 2.4.1.129 VspiD_010100007940
PBP Peptidoglycan transpeptidase-class B 2.4.1.129 VspiD_010100017450
PBP Peptidoglycan synthetase FtsI-class B 2.4.1.129 VspiD_010100019135
PBP Cell elongation specific D,D-transpeptidase- class B 2.4.1.129 VspiD_010100018680
The information for MurB and MurC is in bold. EC # denotes enzyme classification number.
FIGURE 3 | Domain mapping of the MurB/CVs fusion enzyme of V.
spinosum and the individual MurB and MurC enzymes from E. coli
showing the predicted Pfam domains and residue locations of the
individual domains.
genes, respectively. These mutations result in a temperature-
sensitive growth phenotype where the mutants are able to
grow at the permissive temperature of 30◦C, but not at the
non-permissive temperature of 42◦C (Matsuzawa et al., 1969;
Miyakawa et al., 1972). To answer the question of whether
the fusion gene is able to complement the murB and murC
E. coli mutants, the mutant strains were transformed with
an empty vector (pBAD33) or with a vector containing the
murB/C gene (pBAD33::murB/CVs). Using replica-plating, the
results from this analysis demonstrate that at the permissive
temperature of 30◦C, the mutant strains harboring the vector
control (pBAD33) and the vector containing the recombinant
gene (pBAD33::murB/CVs) were both able to grow. However,
when exposed to the non-permissive temperature of 42◦C, only
the strains expressing the murB/C recombinant gene were able
to grow (Figure 4A). This result was corroborated by assessing
bacterial growth in liquid medium over a period of 24 h. At
30◦C the mutants harboring the vector-only and the murB/C−
expressing vector grew as expected. The growth phenotype at the
non-permissive temperature of 42◦C demonstrated that only the
mutant strains expressing the murB/C gene were able to grow
when compared to the vector-only controls (Figure 4B). The lack
of growth based on the optical density of the vector-only controls
at 42◦C can be attributed to rapid lysis of the cells due to the lack
of proper peptidoglycan synthesis (Figure 4B). The assessment
of crude soluble protein extracts from the complementation
experiment using SDS-PAGE analysis confirmed the production
of the recombinant MurB/C fusion enzyme (∼87.3 kDa) in the
mutant backgrounds grown at 42◦C that was not present in
the extracts from the mutant harboring the vector-only control
when both were under inducing conditions using arabinose
(Figure 4C). Together, these analyses demonstrated that the
recombinant MurB/C fusion enzyme from V. spinosum was
endowed with the reductase (MurB) and ligase (MurC) activities,
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and that the amount produced was sufficient to sustain the
growth of the E. colimutants.
Attempts to clone and assay the in vivo activity of the
individual MurB and MurC domains of the MurB/CVs fusion
protein were thenmade. Protein dissection was performed on the
basis of the mapping experiments described above, i.e., alignment
of the V. spinosum protein sequence with that of MurB and
MurC ortholog proteins from E. coli. These two domains were
cloned in the pTrcHis60 vector, in each case in two versions: with
the MurC domain starting at the Met1 residue and terminating
either at the Gly477 or the Val481 residue, and the MurB domain
starting either at the Gly479 or the Lys482 residue (preceded
by a Met residue) and terminating at the last residue (Leu770)
of the fusion protein. The two pTrcHis60::murCVs constructs
thus generated complemented the thermosensitivemurCmutant
strain H1119, indicating that the shortest version ending at
Gly477 clearly exhibited MurC activity. IPTG was not required
for complementation, indicating that basal expression of the
murCVs domain from the pTrcHis60 vector was sufficient to
sustain cell growth and viability of the murC mutant at the
non-permissive temperature of 42◦C (Supplemental Figure 1).
However, the two other pTrcHis60::murBVs constructs failed to
complement the growth defect of the murB mutant strain ST5
and induction of gene expression with 0.5 mM IPTG yielded the
same result. The latter finding could be interpreted in several
ways: inappropriate design of themurB domain initiation codon,
physical instability of these truncated forms of the fusion protein,
or inability of the MurB domain to function independently
(absolute requirement for the presence of the MurC domain).
Our data show that this is not the case for the MurC domain
whose activity did not depend on the presence of the MurB
domain.
Properties and Kinetic Parameters of MurC
Activity from MurB/CVs
The in vitro L-alanine-ligase activity of the MurB/CVs fusion
enzyme was revealed using a radioactive assay, which was
also used to determine the properties and kinetic parameters
(Table 3). The optimal pH and temperature for MurCVs were
found to be 9.0 and 44–46◦C, respectively. As it is the case for
the other Mur ligases (Barreteau et al., 2008), magnesium ions
were essential for the activity: the optimal concentration was
10mM. It was shown that the addition of 10mM ammonium
sulfate and 0.5mg.mL−1 BSA increased the activity by 35 and
FIGURE 4 | Functional complementation analysis of the E. coli murB and murC mutants. (A) Replica-plating experiment of the murC and murB mutants
transformed with pBAD33 and pBAD33::murB/CVs grown at 30 and 42
◦C. (B) Analysis of the complementation experiment at 30 and 42◦C in liquid culture assessing
the growth phenotype by measurement of the optical density (OD) at 600 nm for a 24 h period. The growth experiments were done four times giving the similar growth
profiles. The graphs in (B) represent one of those growth curves. (C) SDS-PAGE analysis of proteins from the complementation experiment to assess the expression
of MurB/C in the mutant backgrounds. Lane (1), protein ladder (kDa). Lane (2), 10 µg of protein extract from the E. coli murC mutant harboring pBAD33 grown at
30◦C. Lane (3), 10 µg of protein extract from the E. coli murC mutant harboring pBAD33::murB/CVsgrown at 42
◦C. Lane (4), 10 µg of protein extract from the E. coli
murB mutant harboring pBAD33 grown at 30◦C. Lane (5), 10 µg of protein extract from the E. coli murB mutant harboring pBAD33::murB/CVsgrown at 42
◦C. Crude
extracts were obtained via sonication after 24 h from the samples grown at 30◦C and 42◦C. The black arrows show expression of the MurB/C recombinant enzyme.
The proteins were resolved on a 10% (w/v) acrylamide gel and stained with Coomassie blue for visualization.
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TABLE 3 | Properties and apparent kinetic parameters of V. spinosum
MurC in comparison with its orthologs from E. coli and C. trachomatis.
Kinetic parameter MurCVs
a MurCEc
b MurCCt
c
Optimal pH 9.0 8.6 8.0–8.5
Optimal Mg2+ concentration (mM) 10 10–20 20
Optimal temperature (◦C) 44–46 45 ndd
KATPm (µM) 470 ± 160 450 162
KUDP−MurNAcm (µM) 90 ± 25 100 196
KL−Alam (µM) 25 ± 10 20 124
Vmax (nmol.min−1.mg−1 ) 5500 ± 50 17300 73.8
aThe apparent kinetic parameters were determined as described in Section Materials and
Methods. The concentrations of the fixed substrates were 5 mM for ATP, 1 mM for UDP-
MurNAc, and 0.2 mM for L-Ala. The concentration ranges for the varied substrates were
0.2–5 mM for ATP, 25–500 µM for UDP-MurNAc, and 10–400 µM for L-Ala.
bFrom (Liger et al., 1995).
cFrom (Hesse et al., 2003).
dnd, not determined.
TABLE 4 | Specificity of MurCVs for the amino acid substrate.
Substrate Enzymatic activity (nmol.min−1.mg−1)a
L-Ala 4900 ± 250
L-Ser 3200 ± 130
Gly 3570 ± 220
aDetermined as described in Section Materials and Methods with fixed concentrations of
ATP (5mM), UDP-MurNAc (1.5mM), and amino acid (1.5mM).
55%, respectively. With L-alanine as the amino acid substrate,
the apparent kcat of the enzyme was 480min
−1 (Vmax, ca.
5500 nmol.min−1.mg−1). Amino acids Gly and L-Ser, which are
found at position 1 of the peptide stem in some bacteria (Schleifer
and Kandler, 1972; Vollmer et al., 2008), were also tested as
substrates (Table 4). L-Ala was the best substrate, which is in
agreement with the amino acid composition of V. spinosum
peptidoglycan (McGroty et al., 2013). However, the difference
with the two others was not as important as for the E. coliMurC
ortholog (Liger et al., 1995).
Attempts to Demonstrate the In vitro MurB
Activity from MurB/CVs
Several attempts were made to measure the in vitro reductase
activity of MurB/CVs with two assays: a spectrophotometric
assay using commercial UDP-GlcNAc-EP and NADPH, and a
coupled MurA/MurB assay using UDP-[14C]GlcNAc and E. coli
MurA. However, neither decrease of absorbance at 340 nm nor
appearance of labeled UDP-MurNAc occurred, even at high
protein concentrations. It was checked that the expected reaction
took place in both assays when MurB/CVs was replaced by E. coli
MurB (data not shown). In order to ascertain that the absence
of reaction in the coupled assay was not due to strong inhibition
by the MurB product, L-alanine, ATP, and Mg2+ were added so
that the MurCVs activity might displace the reaction toward the
right. A new radioactive compound appeared, but its retention
time (25 min) was not consistent with that of UDP-MurNAc-L-
Ala (20min) (data not shown). It was presumably the result of the
FIGURE 5 | Purification of MurB/C by affinity chromatography. Lane (1),
protein ladder (kDa). Lane (2), 0.5 µg of purified MurB/C. The proteins were
resolved on a 10% (w/v) acrylamide gel and stained with Coomassie blue for
visualization.
direct addition of L-alanine to UDP-GlcNAc-EP, a reaction that
has been shown to occur with E. coliMurC (Liger et al., 1995).
Is MurB/CVs Active as a Fusion Enzyme
in vivo?
The SDS-PAGE showing the expression of the MurB/CVs in the
murB and murC mutant backgrounds demonstrated that the
recombinant enzyme was not cleaved in E. coli (Figure 4C).
However, given the fact that there is a 100-residue linker region
between the MurC and MurB domains (Figure 3), we were
interested in answering the question of whether the fusion
enzyme is cleaved in V. spinosum. This would indicate that after
translation, the enzyme is processed by a protease to create two
separate and distinct polypeptides ofMurB andMurC. To answer
this question, the purified recombinant enzyme (Figure 5) was
used in a cleavage assay using crude soluble protein extract from
V. spinosum. The assay showed that the recombinant enzyme was
not cleaved when incubated with an extract from V. spinosum
over a period of 120min (Figure 6). It should be noted that
the result was consistent when the assay was done using several
concentrations of V. spinosum protein extract of up to 15 µg and
several buffer systems with varying pH values (data not shown).
Based on the complementation, and supported by the cleavage
assay, it is probable that the enzyme is active as a fusion enzyme in
V. spinosum. Fusion enzymes involved in PG biosynthesis are not
a new phenomenon; aMurC/Ddl fusion enzyme fromChlamydia
trachomatis has been characterized and it was shown that the
D-Ala:D-Ala ligase activity of the Ddl domain is dependent
on the fusion structure of the MurC/Ddl protein (McCoy and
Maurelli, 2005). Our present data show that at least the MurC
domain of theV. spinosumMurB/C fusion protein is functionally
independent as its expression allowed complementation of a
temperature-conditionalmurC defect in E. coli.
Unusual MurB and MurC Composition is
Prevalent in the Currently Sequenced
Members of Verrucomicrobia
PhyloPhlAn-generated species tree of the PVC clade supports
the monophyletic placement of the major lineage (SH-likelihood
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FIGURE 6 | Assay to assess cleavage of MurB/C using a crude protein
extract from V. spinosum. Lane (1), protein ladder (kDa). Lane (2), 15 µg of
V. spinosum extract. Lane (3), 15 µg of V. spinosum extract plus 7.5 µg of
purified MurB/C at time zero. Lane (4), 15 µg of V. spinosum extract plus 7.5
µg of purified MurB/C at 60 min. Lane (5), 15 µg of V. spinosum extract plus
7.5 µg of purified MurB/C at 120 min. Lane (6), 7.5 µg of purified MurB/C. The
temperature of the assay was 30◦C. The proteins were resolved on a 10%
(w/v) acrylamide gel and stained with Coomassie blue for visualization.
branch support of >0.90). A slightly lower than average
SH-likelihood support value of 0.94 was observed in the
branch splitting the Chlamydiae and Lentisphaerae clades which
presumably is due to low taxon sampling (N = 1) of the
Lentisphaerae clade (Figure 7A). Fused MurB/C is present in all
the currently sequenced members of Verrucomicrobiales (9/9)
and Methylacidiphilales (3/3). These members usually exhibit
a conserved ftsW-murG-murB/C-ddlB-ftsQ gene organization
(Figure 7B) with the exception of V. spinosum DSM 4138, the
type species and type strain for the genus Verrucomicrobium
and species V. spinosum, respectively. In V. spinosum DSM
4138, the murB/C gene is flanked by genes that are not
directly related to cell-wall synthesis. However, the monophyletic
grouping of MurB/C protein (including that ofV. spinosumDSM
4138) suggests that fused MurB/C is an authentic molecular
signature in specific lineages of the phylum Verrucomicrobia
and is not a result of inter-phylum horizontal gene transfer
(Supplemental Figures 2A,B). TIGRFAM search failed to detect
MurC domain in the predicted proteome from members of
the class Opitutae (Figure 7A, green-colored branch). Despite
lowering the detection threshold limit for MurC to the least
stringent limit, e.g. noise cutoff, the MurC domain still could
not be detected, thus supporting the absence of authentic MurC
domain in this lineage. However, it is worth noting that the
MurB proteins detected in nearly all members from Opitutae are
longer than usual and contain the Mur ligase domain located
at the N-terminal (Supplemental Figure 3 and data not shown),
suggesting that although the N-terminal region has diverged
substantially from the typical MurC, it may still share partially
overlapping function with MurC.
DISCUSSION
In the present paper, the in vivo MurB and MurC activities
of the MurB/CVs fusion enzyme were revealed by functional
complementation experiments. Furthermore, the protein was
shown to be endowed with MurC ligase activity in vitro through
a specific radioactive assay. In Table 3, the properties and kinetic
parameters of the MurCVs activity are compared with those
of a reference ortholog (E. coli) and a phylogenetically related
ortholog (C. trachomatis). The enzymes from V. spinosum and
E. coli are comparable regarding their kinetic parameters. The
maximum velocity of MurCVs is three-fold lower (but the kcat
value is only two-fold lower due to the highmolecular mass of the
fusion enzyme) when compared to the E. coliMurC. In addition,
the optimal pH value (9.0) of the MurCVs falls within the range
found for most Mur ligases (8.0–9.2) (Patin et al., 2009) and the
observed pH optimum is comparable to that of MurE from V.
spinosum (9.6). It is possible that such values of pH ≥9 reflect
environmental factors such as the natural habitat of V. spinosum
(McGroty et al., 2013). On the other hand, MurC enzymes
from V. spinosum and C. trachomatis have quite different kinetic
parameters. The main difference is the maximum velocity, which
is 75-fold lower for C. trachomatis MurC when compared to the
MurC from V. spinosum. Although many reasons can be put
forward to explain such a low maximum velocity, a physiological
explanation might be related to the slower growth rate of C.
trachomatis given the fact that it is an intracellular parasite (Hesse
et al., 2003).
Although L-alanine is the best substrate in vitro, L-serine and
glycine are also reasonable substrates (Table 4). From the in vitro
data, the discrimination between the three amino acids in vivo is
much less obvious than for MurC from E. coli (Liger et al., 1995).
Nevertheless, the determination of the amino acid composition
of PG from V. spinosum proves undoubtedly that L-Ala is the
amino acid found at position 1 of the peptide stem (McGroty
et al., 2013). With C. trachomatis MurC, the discrimination was
even less obvious, since the three amino acids were added to
UDP-MurNAc with similar Vmax/Km values, thereby preventing
us from deducing which amino acid was present in the putative
chlamydial PG (Hesse et al., 2003; Patin et al., 2012). The recent
mass spectrometric detection, from C. trachomatis-infected cell
lysates, of muropeptides with alanine or glycine at position 1
strongly suggests that these amino acid are both used as MurC
substrates by C. trachomatis in vivo (Packiam et al., 2015).
While the MurCVs activity could be totally characterized,
the MurBVs activity could not be detected in vitro, even with
the use of two different assays. Attempts to modify the assay
conditions (different pH value, NADH instead of NADPH) were
unsuccessful. A plausible explanation for the lack of MurBVs
activity could be the denaturation of the MurB domain during
or after the purification steps. Even though a cryoprotectant was
included in the storage buffer, such a phenomenon cannot be
ruled out. Another explanation would be that an unidentified
cofactor(s) is necessary for activity which we are not aware of at
this time. Nevertheless, the functional complementation of the E.
coli murB thermosensitive strain by the murB/CVs gene proves
that the MurBVs domain is active in in vivo conditions.
Based on phylogenetic and protein domain scanning, most
members of the Verrucomicrobia possess different compositions
of MurB and MurC proteins. In some lineages, both proteins
are fused as is the case for V. spinosum. In others, the MurC
seems to be absent. Given the phenotype of Verrucomicrobia
regarding the unusual body plan with respect to wart-like and
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FIGURE 7 | (A) Species-tree of the Planctomycetes, Verrucomicrobia, and Chlamydiae (PVC) clade constructed using 400 universal proteins. Values next to each
branch node represent SH-like branch supports as calculated by FastTree2 (Price et al., 2010). The scale bar indicates the number of substitutions per site. The tree
was rooted with members from the phylum Fusobacteria as outgroup. Asterisk sign indicates lineage possessing a longer than usual MurB protein (>600 amino acid
residues) and blue circle with the letter “M” indicates highly-fragmented genome that was derived from metagenomic assembly. The color designations for colored
taxons are as follows: red for missing MurB and MurC, pink for missing MurC and MurB detected at slightly below the TIGR00179 trusted-cutoff score of 144.5 (142
> χ > 144.5), green for missing MurC and blue for fused MurB/C. (B) Gene neighborhood of fused murB/C ORFs. Blue circle represents fts gene and letter within the
circle represents the respective fts gene component. LysM-containing protein coding genes are indicated with a triangle and genes without label code for hypothetical
proteins. Contig numbers are indicated next to species with draft genome sequence.
projections radiating from the central body, one would expect
that PG biosynthesis would have an integral role pertaining to the
shape of the bacterium (McGroty et al., 2013). Theoretically, the
possession of a fusion protein that catalyzes sequential steps in a
particular pathway may constitute an advantage when compared
to a system where these orthologous proteins are separate.
These advantages may include control of the expression of two
genes as a single unit, substrate channeling due to proximity
of the catalysts, higher catalytic activities, etc. Whether such an
advantage, if it exists, influences growth and development of V.
spinosum is currently not known. Further studies to determine
the structure of theMurB/C fusion enzymewould help shed some
light regarding the catalytic properties of the enzyme, especially
since we were not able to demonstrate the MurB activity.
In summary, we present the first description of a MurB/C
fusion enzyme from V. spinosum. In vitro biochemical analyses
demonstrated that the enzyme is capable of catalyzing the ligase
(MurC) reaction at position 1 on the peptide stem. In vitro
analyses to demonstrate the MurB reductase were not successful
even though in vivo analyses demonstrated that the fusion gene
is able to functionally complement E. coli strains that harbor
mutations in themurB andmurC genes. Furthermore, dissection
experiments showed that the MurB domain of the fusion protein
was not essential for the UDP-N-acetylmuramate::L-alanine
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ligase activity of the MurC domain. As this is the first description
of a MurB/C fusion enzyme, there are no structural studies in
the literature. Therefore, studies to solve the structure of fusion
enzymes such as MurB/CVs and MurC/Ddl from C. trachomatis
would help elucidate properties of the enzyme and have the
potential to provide information regarding the rational design
and/or identification of compounds that are deemed inhibitory
and that could be developed as antibiotics. As such, this study
lays the foundation regarding the further understanding of the
kinetic, physical, and structural properties of a novel enzyme
involved in the synthesis of PG.
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Supplemental Figure 1 | Growth of E. coli murC thermosensitive strain
H1119 transformed by vector pTrcHis60 (A), pTrcHis60::murCEc (B),
pTrcHis60::murCVs-1 (C), and pTrcHis60::murCVs-2 (D).
Supplemental Figure 2 | Maximum likelihood tree of (A) MurB and (B)
MurC proteins. Both trees are constructed using IQ-TREE version 1.3.10 with
the optimized LG+G4 model. Value next to branch corresponds to IQ-TREE
ultrafast bootstrap support value. Taxons containing fused MurB/MurC are
colored red. The scale bar indicates the number of substitutions per site.
Supplemental Figure 3 | Complete InterProScan analysis of
longer-than-usual MurB protein identified from the draft genome of
Verrucomicrobiae bacterium DG1235 (accession number: ABSI01). The
MurC domain corresponding to InterProScan ID IPR005758 (HAMAP: MF_00046;
TIGRFAMs: TIGR01082) was absent from this MurB protein. However, domains
corresponding to a general Mur ligase (N-terminal catalytic, central, and
C-terminal domains) are present in the N-terminal region.
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